1607 Capital Partners’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-83,928
Closed -$1.4M 136
2024
Q1
$1.4M Sell
83,928
-103,400
-55% -$1.6M 0.11% 117
2023
Q4
$2.8M Sell
187,328
-26,872
-13% -$391K 0.2% 102
2023
Q3
$3.1M Hold
214,200
0.23% 95
2023
Q2
$3.27M Hold
214,200
0.23% 92
2023
Q1
$3.24M Hold
214,200
0.23% 95
2022
Q4
$2.97M Buy
214,200
+36,100
+20% +$510K 0.2% 98
2022
Q3
$2.42M Hold
178,100
0.19% 91
2022
Q2
$2.61M Buy
178,100
+50,900
+40% +$786K 0.18% 90
2022
Q1
$2.11M Buy
127,200
+38,900
+44% +$683K 0.12% 91
2021
Q4
$1.72M Buy
+88,300
New +$1.72M 0.09% 92

Other funds holding BCAT

1607 Capital Partners's BCAT Position: Q2 2024 in Review

1607 Capital Partners sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2024, closing a stake of 83,928 shares — an estimated $1.4M sold.

1607 Capital Partners first reported a position in BCAT in Q4 2021 and held it in 10 quarters. The position peaked at $3.27M in Q2 2023. 86 funds tracked by Wall St. Rank hold BCAT as of Q2 2024.

  • 1607 Capital Partners reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2024 after selling out during the quarter.
  • 1607 Capital Partners sold 83,928 BlackRock Capital Allocation Term Trust shares in Q2 2024, an estimated $1.4M.
  • 1607 Capital Partners first reported a position in BlackRock Capital Allocation Term Trust in Q4 2021 and held it in 10 quarters.
  • 1607 Capital Partners's BlackRock Capital Allocation Term Trust position peaked at $3.27M in Q2 2023.
  • 86 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2024.

Based on 1607 Capital Partners's 13F filing for Q2 2024, filed 8 Aug 2024.